Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 13374-13375 [2017-04678]
Download as PDF
13374
Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices
(VA). Applicants filing for Title II
survivor benefits at the VA complete
Form SSA–24, which the VA forwards
to SSA for processing. SSA uses the
information to determine eligibility for
benefits. The respondents are survivors
of deceased armed services personnel
who are applying for benefits at the VA.
Type of Request: Revision of an OMBapproved information collection.
Modality of completion
Number of
respondents
Frequency of
response
Average
burden per
response
(minutes)
Estimated
total annual
burden
(hours)
SSA–24 ............................................................................................................
3,200
1
15
800
Dated: March 6, 2017.
Naomi R. Sipple,
Reports Clearance Officer, Social Security
Administration.
state.gov). The mailing address is U.S.
Department of State, L/PD, SA–5, Suite
5H03, Washington, DC 20522–0505.
Alyson Grunder,
Deputy Assistant Secretary for Policy, Bureau
of Educational and Cultural Affairs,
Department of State.
[FR Doc. 2017–04712 Filed 3–9–17; 8:45 am]
[FR Doc. 2017–04827 Filed 3–9–17; 8:45 am]
DEPARTMENT OF STATE
Alyson Grunder,
Deputy Assistant Secretary for Policy, Bureau
of Educational and Cultural Affairs,
Department of State.
BILLING CODE 4710–05–P
BILLING CODE 4191–02–P
[FR Doc. 2017–04828 Filed 3–9–17; 8:45 am]
[Public Notice 9912]
BILLING CODE 4710–05–P
sradovich on DSK3GMQ082PROD with NOTICES
Notice of Determinations; Culturally
Significant Objects Imported for
Exhibition Determinations:
‘‘Revoliutsiia! Demonstratsiia!: Soviet
Art Put to the Test’’ Exhibition
Summary: Notice is hereby given of
the following determinations: Pursuant
to the authority vested in me by the Act
of October 19, 1965 (79 Stat. 985; 22
U.S.C. 2459), E.O. 12047 of March 27,
1978, the Foreign Affairs Reform and
Restructuring Act of 1998 (112 Stat.
2681, et seq.; 22 U.S.C. 6501 note, et
seq.), Delegation of Authority No. 234 of
October 1, 1999, Delegation of Authority
No. 236–3 of August 28, 2000 (and, as
appropriate, Delegation of Authority No.
257–1 of December 11, 2015), I hereby
determine that certain objects to be
included in the exhibition
‘‘Revoliutsiia! Demonstratsiia!: Soviet
Art Put to the Test,’’ imported from
abroad for temporary exhibition within
the United States, are of cultural
significance. The objects are imported
pursuant to a loan agreement with the
foreign owner or custodian. I also
determine that the exhibition or display
of the exhibit objects at The Art Institute
of Chicago, Chicago, Illinois, from on or
about October 29, 2017, until on or
about January 14, 2018, and at possible
additional exhibitions or venues yet to
be determined, is in the national
interest. I have ordered that Public
Notice of these Determinations be
published in the Federal Register.
For Further Information Contact: For
further information, including a list of
the imported objects, contact the Office
of Public Diplomacy and Public Affairs
in the Office of the Legal Adviser, U.S.
Department of State (telephone: 202–
632–6471; email: section2459@
VerDate Sep<11>2014
18:37 Mar 09, 2017
632–6471; email: section2459@
state.gov). The mailing address is U.S.
Department of State, L/PD, SA–5, Suite
5H03, Washington, DC 20522–0505.
Jkt 241001
DEPARTMENT OF STATE
[Public Notice 9913]
DEPARTMENT OF TRANSPORTATION
Notice of Determinations; Culturally
Significant Objects Imported for
Exhibition Determinations: ‘‘Gauguin:
Artist as Alchemist’’ Exhibition
Federal Motor Carrier Safety
Administration
Summary: Notice is hereby given of
the following determinations: Pursuant
to the authority vested in me by the Act
of October 19, 1965 (79 Stat. 985; 22
U.S.C. 2459), E.O. 12047 of March 27,
1978, the Foreign Affairs Reform and
Restructuring Act of 1998 (112 Stat.
2681, et seq.; 22 U.S.C. 6501 note, et
seq.), Delegation of Authority No. 234 of
October 1, 1999, Delegation of Authority
No. 236–3 of August 28, 2000 (and, as
appropriate, Delegation of Authority No.
257–1 of December 11, 2015), I hereby
determine that the objects to be
included in the exhibition ‘‘Gauguin:
Artist as Alchemist,’’ imported from
abroad for temporary exhibition within
the United States, are of cultural
significance. The objects are imported
pursuant to loan agreements with the
foreign owners or custodians. I also
determine that the exhibition or display
of the exhibit objects at The Art Institute
of Chicago, Chicago, Illinois, from on or
about June 25, 2017, until on or about
September 10, 2017, and at possible
additional exhibitions or venues yet to
be determined, is in the national
interest. I have ordered that Public
Notice of these Determinations be
published in the Federal Register.
For Further Information Contact: For
further information, including a list of
the imported objects, contact the Office
of Public Diplomacy and Public Affairs
in the Office of the Legal Adviser, U.S.
Department of State (telephone: 202–
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
[Docket No. FMCSA–2012–0094; FMCSA–
2013–0109]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to renew exemptions for two
individuals from the requirement in the
Federal Motor Carrier Safety
Regulations (FMCSRs) that interstate
commercial motor vehicle (CMV)
drivers have ‘‘no established medical
history or clinical diagnosis of epilepsy
or any other condition which is likely
to cause loss of consciousness or any
loss of ability to control a CMV.’’ The
exemptions enable these individuals
who have had one or more seizures and
are taking anti-seizure medication to
continue to operate CMVs in interstate
commerce.
DATES: Each renewed exemption was
effective on the dates stated in the
discussions below and will expire on
the dates stated in the discussions
below.
SUMMARY:
Ms.
Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE., Room W64–
224, Washington, DC 20590–0001.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\10MRN1.SGM
10MRN1
Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices
Office hours are from 8:30 a.m. to 5
p.m., e.t., Monday through Friday,
except Federal holidays. If you have
questions regarding viewing or
submitting material to the docket,
contact Docket Services, telephone (202)
366–9826.
SUPPLEMENTARY INFORMATION:
I. Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., e.t., Monday through Friday,
except Federal holidays.
Privacy Act: In accordance with 5
U.S.C. 553(c), DOT solicits comments
from the public to better inform its
rulemaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to https://www.regulations.gov,
as described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at https://www.dot.gov/
privacy.
II. Background
sradovich on DSK3GMQ082PROD with NOTICES
On October 14, 2016, FMCSA
published a notice announcing its
decision to renew exemptions for two
individuals from the Epilepsy and
Seizure Disorders prohibition in 49 CFR
391.41(b)(8) to operate a CMV in
interstate commerce and requested
comments from the public (81 FR
71176). The public comment period
ended on November 14, 2016, and no
comments were received.
As stated in the previous notice,
FMCSA has evaluated the eligibility of
these applicants and determined that
renewing these exemptions would
achieve a level of safety equivalent to or
greater than the level that would be
achieved by complying with the current
regulation 49 CFR 391.41(b)(8).
The physical qualification standard
for drivers regarding epilepsy found in
49 CFR 391.41(b)(8) states that a person
is physically qualified to drive a CMV
if that person:
Has no established medical history or
clinical diagnosis of epilepsy or any other
condition which is likely to cause the loss of
consciousness or any loss of ability to control
a CMV.
In addition to the regulations, FMCSA
has published advisory criteria to assist
Medical Examiners in determining
VerDate Sep<11>2014
18:37 Mar 09, 2017
Jkt 241001
whether drivers with certain medical
conditions are qualified to operate a
CMV in interstate commerce. [49 CFR
part 391, APPENDIX A TO PART 391—
MEDICAL ADVISORY CRITERIA,
section H. Epilepsy: § 391.41(b)(8),
paragraphs 3, 4, and 5.]
III. Discussion of Comments
FMCSA received no comments in this
preceding.
IV. Conclusion
Based upon its evaluation of the two
renewal exemption applications and no
comments received, FMCSA confirms
its’ decision to exempt the following
drivers from the Epilepsy and Seizure
Disorders requirement in 49 CFR 391.41
(b)(8), subject to the requirements cited
above.
As of February 10, 2016, Victor
Marquez (ID), has satisfied the renewal
conditions for obtaining an exemption
from the Epilepsy and Seizure Disorders
prohibition in 49 CFR 391.41(b)(8), from
driving CMVs in interstate commerce.
This individual’s name was misspelled
as Victor Martinez (ID), in the October
14, 2016 notice requesting comment (81
FR 71176). This driver was included in
FMCSA–2012–0094. This exemption
was effective on February 10, 2016, and
will expire on February 10, 2018.
As of February 14, 2016, John Johnson
(WI), has satisfied the renewal
conditions for obtaining an exemption
from the Epilepsy and Seizure Disorders
prohibition in 49 CFR 391.41(b)(8), from
driving CMVs in interstate commerce
(81 FR 71176). This driver was included
in FMCSA–2013–0109. This exemption
was effective on February 14, 2016, and
will expire on February 14, 2018.
In accordance with 49 U.S.C. 31315,
each exemption will be valid for two
years from the effective date unless
revoked earlier by FMCSA. The
exemption will be revoked if the
following occurs: (1) The person fails to
comply with the terms and conditions
of the exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained prior to being granted;
or (3) continuation of the exemption
would not be consistent with the goals
and objectives of 49 U.S.C. 31136 and
31315.
Issued on: February 27, 2017.
Larry W. Minor,
Associate Administrator for Policy.
13375
DEPARTMENT OF TRANSPORTATION
Office of the Secretary
[Docket No. DOT–OST–2016–0204]
Exploring Industry Practices on
Distribution and Display of Airline
Fare, Schedule, and Availability
Information
Office of the Secretary (OST),
Department of Transportation (DOT).
ACTION: Suspension of comment period.
AGENCY:
DOT is suspending the public
comment period for the Request for
Information (RFI) Exploring Industry
Practices on Distribution and Display of
Airline Fare, Schedule, and Availability
Information, effective March 10, 2017.
DOT published the RFI on October 31,
2016, and the comment period initially
closed on December 30, 2016. On
December 22, 2016, DOT extended the
comment period to March 31, 2017. The
suspension of the comment period will
allow the President’s appointees the
opportunity to review and consider this
action.
DATES: The comment period for this RFI
is indefinitely suspended effective
March 10, 2017.
ADDRESSES: Docket: For access to the
docket to read background documents
and comments received, go to https://
www.regulations.gov or to the street
address listed above. Follow the online
instructions for accessing the docket.
FOR FURTHER INFORMATION CONTACT:
Kyle-Etienne Joseph, Trial Attorney, or
Kimberly Graber, Chief, Consumer
Protection and Competition Law
Branch, Office of the Assistant General
Counsel for Aviation Enforcement and
Proceedings, U.S. Department of
Transportation, 1200 New Jersey Ave.
SE., Washington, DC 20590, 202–366–
9342, 202–366–7152 (fax), kyleetienne.joseph@dot.gov or
kimberly.graber@dot.gov (email).
SUMMARY:
Issued this 2nd day of March 2017, in
Washington, DC.
Judith S. Kaleta,
Deputy General Counsel.
[FR Doc. 2017–04696 Filed 3–9–17; 8:45 am]
BILLING CODE 4910–9X–P
DEPARTMENT OF TREASURY
Internal Revenue Service
Electronic Tax Administration
Advisory Committee (ETAAC);
Nominations
[FR Doc. 2017–04678 Filed 3–9–17; 8:45 am]
Internal Revenue Service,
Department of Treasury.
AGENCY:
BILLING CODE 4910–EX–P
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\10MRN1.SGM
10MRN1
Agencies
[Federal Register Volume 82, Number 46 (Friday, March 10, 2017)]
[Notices]
[Pages 13374-13375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04678]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2012-0094; FMCSA-2013-0109]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to renew exemptions for two
individuals from the requirement in the Federal Motor Carrier Safety
Regulations (FMCSRs) that interstate commercial motor vehicle (CMV)
drivers have ``no established medical history or clinical diagnosis of
epilepsy or any other condition which is likely to cause loss of
consciousness or any loss of ability to control a CMV.'' The exemptions
enable these individuals who have had one or more seizures and are
taking anti-seizure medication to continue to operate CMVs in
interstate commerce.
DATES: Each renewed exemption was effective on the dates stated in the
discussions below and will expire on the dates stated in the
discussions below.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224,
Washington, DC 20590-0001.
[[Page 13375]]
Office hours are from 8:30 a.m. to 5 p.m., e.t., Monday through Friday,
except Federal holidays. If you have questions regarding viewing or
submitting material to the docket, contact Docket Services, telephone
(202) 366-9826.
SUPPLEMENTARY INFORMATION:
I. Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday,
except Federal holidays.
Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to https://www.regulations.gov, as described in
the system of records notice (DOT/ALL-14 FDMS), which can be reviewed
at https://www.dot.gov/privacy.
II. Background
On October 14, 2016, FMCSA published a notice announcing its
decision to renew exemptions for two individuals from the Epilepsy and
Seizure Disorders prohibition in 49 CFR 391.41(b)(8) to operate a CMV
in interstate commerce and requested comments from the public (81 FR
71176). The public comment period ended on November 14, 2016, and no
comments were received.
As stated in the previous notice, FMCSA has evaluated the
eligibility of these applicants and determined that renewing these
exemptions would achieve a level of safety equivalent to or greater
than the level that would be achieved by complying with the current
regulation 49 CFR 391.41(b)(8).
The physical qualification standard for drivers regarding epilepsy
found in 49 CFR 391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person:
Has no established medical history or clinical diagnosis of
epilepsy or any other condition which is likely to cause the loss of
consciousness or any loss of ability to control a CMV.
In addition to the regulations, FMCSA has published advisory
criteria to assist Medical Examiners in determining whether drivers
with certain medical conditions are qualified to operate a CMV in
interstate commerce. [49 CFR part 391, APPENDIX A TO PART 391--MEDICAL
ADVISORY CRITERIA, section H. Epilepsy: Sec. 391.41(b)(8), paragraphs
3, 4, and 5.]
III. Discussion of Comments
FMCSA received no comments in this preceding.
IV. Conclusion
Based upon its evaluation of the two renewal exemption applications
and no comments received, FMCSA confirms its' decision to exempt the
following drivers from the Epilepsy and Seizure Disorders requirement
in 49 CFR 391.41 (b)(8), subject to the requirements cited above.
As of February 10, 2016, Victor Marquez (ID), has satisfied the
renewal conditions for obtaining an exemption from the Epilepsy and
Seizure Disorders prohibition in 49 CFR 391.41(b)(8), from driving CMVs
in interstate commerce. This individual's name was misspelled as Victor
Martinez (ID), in the October 14, 2016 notice requesting comment (81 FR
71176). This driver was included in FMCSA-2012-0094. This exemption was
effective on February 10, 2016, and will expire on February 10, 2018.
As of February 14, 2016, John Johnson (WI), has satisfied the
renewal conditions for obtaining an exemption from the Epilepsy and
Seizure Disorders prohibition in 49 CFR 391.41(b)(8), from driving CMVs
in interstate commerce (81 FR 71176). This driver was included in
FMCSA-2013-0109. This exemption was effective on February 14, 2016, and
will expire on February 14, 2018.
In accordance with 49 U.S.C. 31315, each exemption will be valid
for two years from the effective date unless revoked earlier by FMCSA.
The exemption will be revoked if the following occurs: (1) The person
fails to comply with the terms and conditions of the exemption; (2) the
exemption has resulted in a lower level of safety than was maintained
prior to being granted; or (3) continuation of the exemption would not
be consistent with the goals and objectives of 49 U.S.C. 31136 and
31315.
Issued on: February 27, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017-04678 Filed 3-9-17; 8:45 am]
BILLING CODE 4910-EX-P